Takeda Pharmaceutical Co Ltd (TAK)
13.37
+0.10
(+0.75%)
USD |
NYSE |
May 03, 16:00
13.36
0.00 (0.00%)
Pre-Market: 20:00
Takeda Pharmaceutical Cash from Operations (TTM): 5.353B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.353B |
September 30, 2023 | 7.044B |
June 30, 2023 | 7.260B |
March 31, 2023 | 7.236B |
December 31, 2022 | 8.276B |
September 30, 2022 | 8.580B |
June 30, 2022 | 9.130B |
March 31, 2022 | 10.00B |
December 31, 2021 | 10.27B |
September 30, 2021 | 9.477B |
June 30, 2021 | 9.705B |
March 31, 2021 | 9.536B |
December 31, 2020 | 7.549B |
September 30, 2020 | 6.676B |
June 30, 2020 | 6.419B |
March 31, 2020 | 6.162B |
December 31, 2019 | 5.545B |
September 30, 2019 | 5.086B |
June 30, 2019 | 3.691B |
March 31, 2019 | 2.963B |
December 31, 2018 | 3.050B |
September 30, 2018 | 2.962B |
June 30, 2018 | 3.110B |
March 31, 2018 | 3.410B |
December 31, 2017 | 3.395B |
Date | Value |
---|---|
September 30, 2017 | 2.831B |
June 30, 2017 | 2.618B |
March 31, 2017 | 2.417B |
December 31, 2016 | 62.76M |
September 30, 2016 | 527.15M |
June 30, 2016 | 528.82M |
March 31, 2016 | 212.43M |
December 31, 2015 | 1.766B |
September 30, 2015 | 1.632B |
June 30, 2015 | 1.705B |
March 31, 2015 | 1.669B |
December 31, 2014 | 2.365B |
September 30, 2014 | 2.309B |
June 30, 2014 | 2.508B |
March 31, 2014 | 1.485B |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
3.691B
Minimum
Jun 2019
10.27B
Maximum
Dec 2021
7.526B
Average
7.260B
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Astellas Pharma Inc | 1.603B |
Nxera Pharma Co Ltd | -37.58M |
PeptiDream Inc | 88.53M |
Stemcell Holdings Inc | 2.544M |
Healios KK | -20.11M |